The polyubiquitin Ubc gene modulates histone H2A monoubiquitylation in the R6/2 mouse model of Huntington's disease

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 2645-2657

  Bett, John S ^a   Benn, Caroline L ^a   Ryu, Kwon Yul ^b,c   Kopito, Ron R ^b   Bates, Gillian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b STANFORD UNIVERSITY   (United States)

^c University of Seoul   (South Korea)

Author keywords

Aggregation; Histone modification; Huntington's disease; Neurodegeneration; Polyglutamine; Ubiquitin

Indexed keywords

HISTONE; POLYUBIQUITIN; PRIMER DNA;

ANIMAL; ARTICLE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETICS; HUNTINGTON CHOREA; METABOLISM; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTONES; HUNTINGTON DISEASE; MICE; MICE, KNOCKOUT; POLYUBIQUITIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UBIQUITINATION;

MUS;

EID: 65249165505     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00543.x     Document Type: Article

References (44)

1. Landles C, Bates GP. Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep. 2004 5 : 958 963.
2. Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997 90 : 537 548.
3. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997 277 : 1990 1993.
4. Scherzinger E, Lurz R, Turmaine M, et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 1997 90 : 549 558.
5. Graham RK, Deng Y, Slow EJ, et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell. 2006 125 : 1179 1191.
6. Kazantsev A, Preisinger E, Dranovsky A, et al. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci USA. 1999 96 : 11404 11409.
7. Schaffar G, Breuer P, Boteva R, et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol Cell. 2004 15 : 95 105.
8. Gidalevitz T, Ben-Zvi A, Ho KH, et al. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science. 2006 311 : 1471 1474.
9. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001 292 : 1552 1555.
10. Bowman AB, Yoo SY, Dantuma NP, et al. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet. 2005 14 : 679 691.
11. Bett JS, Goellner GM, Woodman B, et al. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target. Hum Mol Genet. 2006 15 : 33 44.
12. Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, et al. Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci. 2003 23 : 11653 11661.
13. Wang J, Wang CE, Orr A, et al. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J Cell Biol. 2008 180 : 1177 1189.
14. Bennett EJ, Shaler TA, Woodman B, et al. Global changes to the ubiquitin system in Huntington's disease. Nature. 2007 448 : 704 708.
15. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998 392 : 605 608. (Pubitemid 28207717)
16. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature. 1998 395 : 451 452.
17. Maraganore DM, Farrer MJ, Hardy JA, et al. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology. 1999 53 : 1858 1860.
18. Saigoh K, Wang YL, Suh JG, et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet. 1999 23 : 47 51.
19. Kirschner LS, Stratakis CA. Structure of the human ubiquitin fusion gene Uba80 (RPS27a) and one of its pseudogenes. Biochem Biophys Res Commun. 2000 270 : 1106 1110.
20. Ryu KY, Maehr R, Gilchrist CA, et al. The mouse polyubiquitin gene UbC is essential for fetal liver development, cell-cycle progression and stress tolerance. EMBO J. 2007 26 : 2693 2706.
21. Ryu KY, Sinnar SA, Reinholdt LG, et al. The mouse polyubiquitin gene Ubb is essential for meiotic progression. Mol Cell Biol. 2008 28 : 1136 1146.
22. Finley D, Ozkaynak E, Varshavsky A. The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell. 1987 48 : 1035 1046.
23. Finley D, Bartel B, Varshavsky A. The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature. 1989 338 : 394 401.
24. Hockly E, Cordery PM, Woodman B, et al. Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann Neurol. 2002 51 : 235 242.
25. Hockly E, Tse J, Barker AL, et al. Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease. Neurobiol Dis. 2006 21 : 228 236.
26. Ryu KY, Baker RT, Kopito RR. Ubiquitin-specific protease 2 as a tool for quantification of total ubiquitin levels in biological specimens. Anal Biochem. 2006 353 : 153 155.
27. Woodman B, Butler R, Landles C, et al. The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull. 2007 72 : 83 97.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 25 : 402 408.
29. Vandesompele J, De PK, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002 3 : RESEARCH0034.
30. Mimnaugh EG, Bonvini P, Neckers L. The measurement of ubiquitin and ubiquitinated proteins. Electrophoresis. 1999 20 : 418 428.
31. West MH, Bonner WM. Histone 2B can be modified by the attachment of ubiquitin. Nucleic Acids Res. 1980 8 : 4671 4680.
32. Carlson N, Rogers S, Rechsteiner M. Microinjection of ubiquitin: changes in protein degradation in HeLa cells subjected to heat-shock. J Cell Biol. 1987 104 : 547 555.
33. Sadri-Vakili G, Cha JH. Mechanisms of disease: histone modifications in Huntington's disease. Nat Clin Pract Neurol. 2006 2 : 330 338.
34. Wilson SM, Bhattacharyya B, Rachel RA, et al. Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat Genet. 2002 32 : 420 425.
35. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996 87 : 493 506.
36. Goldknopf IL, Busch H. Isopeptide linkage between nonhistone and histone 2A polypeptides of chromosomal conjugate-protein A24. Proc Natl Acad Sci USA. 1977 74 : 864 868.
37. de NM, Mermoud JE, Wakao R, et al. Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev Cell. 2004 7 : 663 676.
38. Wang H, Wang L, Erdjument-Bromage H, et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature. 2004 431 : 873 878.
39. Baarends WM, Wassenaar E, van der LR, et al. Silencing of unpaired chromatin and histone H2A ubiquitination in mammalian meiosis. Mol Cell Biol. 2005 25 : 1041 1053.
40. Dantuma NP, Groothuis TA, Salomons FA, et al. A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. J Cell Biol. 2006 173 : 19 26.
41. Kim MO, Chawla P, Overland RP, et al. Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation. J Neurosci. 2008 28 : 3947 3957.
42. Vissers JH, Nicassio F, van Lohuizen M, et al. The many faces of ubiquitinated histone H2A: insights from the DUBs. Cell Div. 2008 3 : 8.
43. Sadri-Vakili G, Bouzou B, Benn CL, et al. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet. 2007 16 : 1293 1306.
44. Hockly E, Richon VM, Woodman B, et al. Suberoylanilide hydroxamid acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA. 2003 100 : 2041 2046.